Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Tetra borrowing $ from the Cellvera in Dubai India

<< Previous

Bullboard Posts

Next >>

Comment by Realnewsalways1on Sep 06, 2022 1:51pm

151 Views

Post# 34944445

RE: Tetra borrowing $ from the Cellvera in Dubai India

Sam,,,you know this is a research company when you supposedly invested in it but then again you are paid to bash. There is info on any company on any listing on what they are doing wrong and you just repeat repeat and repeat...This news this moring supports the DATA ROOM of research on ARDS003. That is positive period....No one said this NR will take them to revenue, ONLY YOU......SO SH** the F...U

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market